Neutral
Simulations Plus, Inc. director Sharlene Evans was granted 2,117 shares of common stock on May 1, 2026, as part of her independent director compensati...
Bullish
Simulations Plus Inc. (SLP) reported strong fiscal second-quarter results, exceeding market expectations with an EPS of $0.35 and total revenue of $24...
Simulations Plus Inc (SLP) is advancing AI-enabled modeling in drug development, collaborating with large pharmaceutical companies to integrate AI int...
Neutral
John Anthony Dibella II, CRO of Simulations Plus (NASDAQ:SLP), sold 1,000 shares of the company's stock on April 15th at an average price of $13.37, r...